唐伟方 副教授 药物化学专业硕士研究生导师
1988年本科毕业于中国药科大学，2000年获得中国药科大学药物化学专业硕士学位，2008年获得中国药科大学药物化学专业博士学位。
主要研究方向为化学药物的设计与合成，从事抗肿瘤药物的设计、合成和构效关系研究，研究侧重于通过合理药物设计及计算机辅助药物设计，构建新型结构类型的单靶点或多靶点激酶类抑制剂，并评价其生物活性，以期发现具有临床前研究价值的先导化合物。现主持国家自然科学基金面上项目1项。在陆涛课题组指导和培养研究生，本课题组目前承担多项国家和省自然基金项目，并与多家药企进行新药联合开发，科研经费充足。主编和参编学术著作和教材6本，申请中国专利3项，其中1项已获授权。在国内外学术刊物SCI、及核心期刊上已发表论文十余篇。
联系电话：.
Email:tangwf126@126.com
近年发表的主要论文：
[1] Weimin Yang, Yadong Chen, Xiang Zhou, Yazhou Gu, Wenqi Qian, Fan Zhang, Tao Lu*, Weifang Tang* . Design, sythesis and biological evalution of bis-aryl ureas and amides based on 2-amino-3 purinypyridine scaffold as DFG-out B-Raf kinase inhibitors. Eur. J. Med. Chem. 2015,89,581-596
[2] Weimin Yang, Yadong Chen, Yanmin Zhang, Sanzhi Tang ,Hongli Chen, Weifang Tang* and Tao Lu*. Design, Sythesis and Antitumor Activities of Bis- arylureas and Bis-arylamines Based on 1H-benzo[d]imidazole Woiety as Novel B-RafV600E/ VEGFR2 Dual Inhibitors. Lett Drug Des Discov. 2014,11, 1079- 1089
[3] Zeng Wu, Ming Yan, Shi-He Hu, Zhi-Cheng Yu, Yong Zhu, Ya-Dong Chen, Hai-Chun Liu, Yan-Min Zhang, Si-Hui Yao, Wei-Fang Tang*, Tao Lu*. Design, sythesis and biological evalution of indole derivatives as novel inhibitors taegeting B-Raf kinase. Chinese Chemlett. 2014,25,351-354
[4]. Yingyan, Weifang Tang, Yu Zhang, Ding Du, and Taolu. N-Heterocyclic Carbene-Catalyzed Annulations of Enals and Ynals with Indolin-3-ones: Synthesis of 3,4-Dihydropyrano[3,2-b] indol-2-ones. [J] Adv. Synth. Catal. 355:321-326, 2013.（5.532）
[5] Yong Zhu, Xin Chen, Zeng Wu, Yixuan Zheng, Yadong Chen, Weifang Tang*, Tao Lu*. Synthesis and Antitumor Activity of Novel Diaryl Ether Hydroxamic Acids Derivatives as Potential HDAC Inhibitors. Arch Pharm Res. 2012,35(10): 1723-1732
[6].Botao Xin, Weifang Tang, Yue Wang, Guowu Lin, Haichun Liu, Yu Jiao, Yong Zhu, Haoliang Yuan, Yadong Chen, Yao Lu*. Dessign, sythesis and biological evalution of β-carboline derivatives as novel inhibitors targeting B-Raf kinase.[J] Bioorg. Med. Chem. Lett. 22(4): 4783-4786, 2012. (2. 554)
[7] Qingfa Zhou, Xueping Chu, Shen Zhao, Yao Lu, Weifang Tang. BF3·Et2O promoted conjugate additin of ethanethiol to electron-deficient alkynes.[J] Chin. Chem. Let.23(6): 639-642 ,2012.
[8] Huifang Li, Yadong Chen, Shasha Rao, Xiumei Chen, Haichun Liu, Weifang Tang, Yue Wang, Xiang Zhou, Tao Lu*. Recent Advances in the Research and Development of B-Raf Inhibitors.[J] Curr. Med. Chem. 17:1618-1634,2010.
[9]Guowu Lin , Yue Wang, Qingfa Zhou , Weifang Tang , Jian Wang and Tao Lu*. A Facile Synthesis of 3-Substituted 9H-Pyrido[3,4-b]indol-1(2H)-one Derivatives from 3-Substituted β-Carbolines. [J] Molecules. 15: 5680-5691, 2010.
[10]唐伟方，陆涛，颜彩虹，林国武，陈亚东，张陆勇 N,N'-双取代脲类Raf激酶抑制剂及其制备方法和用途 中国专利申请号：3.2；申请日：**(已获授权)